NGS Panels for Haematological Disorders
The SureSeq™ haematology range encompasses a broad range of products to detect genetic aberrations seen in many haematological disorders, such as acute myeloid leukaemia (AML), chronic lymphocytic leukaemia (CLL), chronic myeloid leukaemia (CML), myelodysplastic syndrome (MDS) and myeloproliferative neoplasms (MPN).
SureSeq myPanel™ NGS Custom Cancer Panels
A regularly updated, expert-curated library of pre-optimised cancer panel content for you to select from. Simply mix and match the gene, exonic or intronic content you need to create an NGS cancer panel that meets your exact requirements.
SureSeq myPanel™ NGS Custom AML Panel
Choose your perfect AML NGS panel from our range of fully tested and optimised panel content. Simply mix and match the genes or individual exons you require for your research and get the most out of your sequencing runs.
SureSeq™ Pan-Myeloid Panel
The SureSeq Pan-Myeloid Panel has been designed with input from recognised cancer experts to detect key variants in 70 genes implicated in a wide range of myeloid disorders, including AML, MPN and MDS.
SureSeq™ CLL + CNV Panel
The SureSeq CLL + CNV Panel has been designed in collaboration with recognised cancer experts to detect 12 key genes and 5 chromosomal regions implicated in CLL progression.
SureSeq™ Core MPN Panel
The SureSeq Core MPN Panel delivers accurate detection of somatic variants in 3 clinically relevant myeloid-associated genes, JAK2, MPL and CALR.
SureSeq™ Myeloid Panel
A 25-gene myeloid disorders hybridisation-based NGS enrichment panel with complimentary SureSeq Interpret Software that delivers accurate and easy identification of variants.